Overview

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Patients who were previously enrolled on the LY353381 arm of any LY353381 oncology trial could enroll in this "roll-over" study if they had exhibited clinical benefit from treatment and wished to continue on treatment. Patients were monitored for safety.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company